Parameters | GID phases | TNB | CHN | NGR | KKR | CKR |
---|---|---|---|---|---|---|
Antioxidant activity (DPPH scavenging %) | Crude sample | 85.31 ± 1.55d | 72.05 ± 0.96b | 74.11 ± 0.92c | 70.91 ± 2.91bc | 51.02 ± 1.81a |
Oral phase | 79.17 ± 1.34d | 68.09 ± 0.35c | 68.88 ± 1.1c | 62.22 ± 1.88b | 42.47 ± 0.67a | |
BI (%) | 92.81 | 94.51 | 92.94 | 87.74 | 83.24 | |
Gastric phase | 9.36 ± 0.63b | 9.93 ± 1.03b | 7.25 ± 0.78a | 10.73 ± 0.61c | 7.65 ± 0.37a | |
BI (%) | 10.97 | 13.78 | 9.78 | 15.13 | 14.99 | |
Intestinal phase | 4.7 ± 1.06a | 4.28 ± 0.93a | 3.66 ± 1.43a | 3.55 ± 1.3a | 3.04 ± 1.08a | |
BI (%) | 5.51 | 5.94 | 4.94 | 5.01 | 5.96 | |
Total phenol or TPC (µg GAE/ mL) | Crude sample | 592.96 ± 2.68c | 159.76 ± 3.42b | 936.26 ± 6.87e | 886.96 ± 5.76d | 96.36 ± 1.22a |
Oral phase | 587.85 ± 2.46c | 151.94 ± 2.86b | 900.24 ± 3.97e | 878.09 ± 4.26d | 81.03 ± 1.73a | |
BI (%) | 99.14 | 95.1 | 96.15 | 99 | 84.09 | |
Gastric phase | 34.70 ± 3.94c | 23.98 ± 4.27b | 87.02 ± 1.47e | 74.30 ± 3.99d | 18.66 ± 1.42a | |
BI (%) | 5.85 | 15.01 | 9.29 | 8.38 | 19.37 | |
Intestinal phase | 21.97 ± 2.74c | 12.21 ± 3.11b | 29.93 ± 4.23d | 24.21 ± 1.02 cd | 9.25 ± 2a | |
BI (%) | 3.71 | 7.64 | 3.2 | 1.6 | 9.6 | |
Lipid composition (acid value or %FFA) | Crude sample | 1.126 ± 0.035b | 1.39 ± 0.004c | 1.97 ± 0.08d | 2.11 ± 0.095d | 0.28 ± 0.07a |
Oral phase | 1.12 ± 0.04b | 1.34 ± 0.01c | 1.92 ± 0.05d | 2.01 ± 0.07d | 0.21 ± 0.09a | |
BI (%) | 99.47 | 96.4 | 97.46 | 95.26 | 75 | |
Gastric phase | 1.09 ± 0.05b | 1.12 ± 0.04b | 1.27 ± 0.06c | 1.98 ± 0.09d | 0.21 ± 0.07a | |
BI (%) | 96.8 | 80.58 | 64.47 | 93.84 | 75 | |
Intestinal phase | 0.02 ± 0.01a | 0.04 ± 0.01a | 0.12 ± 0.04a | 0.27 ± 0.08a | 0.02 ± 0.01a | |
BI (%) | 1.78 | 2.88 | 6.09 | 12.8 | 7.14 |